Skip to main content


Fig. 3 | Microbial Cell Factories

Fig. 3

From: Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model

Fig. 3

Effects of oral administration of LL-TSLP on acute DSS-induced inflammation in mice. Mice were orally dosed with LL-WT or LL-TSLP 5 days prior DSS treatment until the end of study. Percentage initial weight (a) and Disease Activity Index (b) were monitored during the whole DSS treatment period. c Histological score of colon segment, d colon histology, e IFN-γ in colon washes and f TGF-β concentrations in supernatants of activated cells from MLN

Back to article page